Moderna
MRNA
#1830
Rank
ยฃ8.12 B
Marketcap
ยฃ20.79
Share price
8.67%
Change (1 day)
-38.21%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: ยฃ8.12 Billion

As of December 2025 Moderna has a market cap of ยฃ8.12 Billion. This makes Moderna the world's 1830th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ8.12 B-33.98%
2024ยฃ12.30 B-58.65%
2023ยฃ29.76 B-47.82%
2022ยฃ57.03 B-25.23%
2021ยฃ76.28 B151.54%
2020ยฃ30.32 B504.16%
2019ยฃ5.01 B26.92%
2018ยฃ3.95 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Moderna was reported to be:

ยฃ8.12 Billion
by Nasdaq info icon info icon
ยฃ8.12 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regulus Therapeutics
RGLS
ยฃ0.42 B-94.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ186.97 B 2,201.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
ยฃ0.62 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ45.43 B 459.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ190.35 B 2,242.97%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
ยฃ6.37 B-21.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ365.19 B 4,395.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
ยฃ2.23 B-72.49%๐Ÿ‡บ๐Ÿ‡ธ USA